The Q4 earnings report for Regeneron Pharmaceuticals (NASDAQ:REGN) was released on Friday, January 30, 2026 at 06:30 AM.
Here’s what investors need to know about the latest announcement.
Earnings
Regeneron Pharmaceuticals beat estimated earnings by 18.0%, reporting an EPS of $11.44 versus an estimate of $9.69.
Revenue was up $95.00 million from the same period last year.
Earnings History Overview
The company beat …